|
2022-08-12 |
2022-08-11 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
1,678,954
+24.1%
10.07
USD 16,907,067
|
1,678,954
+24.1%
|
10.07
|
USD 16,907,067
|
|
|
2022-08-11 |
2022-08-10 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
4,012
+0.1%
10.07
USD 40,401
|
4,012
+0.1%
|
10.07
|
USD 40,401
|
|
|
2022-05-20 |
2022-05-18 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
477,824
+5.8%
5.57
USD 2,661,002
|
477,824
+5.8%
|
5.57
|
USD 2,661,002
|
|
|
2022-01-07 |
2022-01-06 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
300,000
+3.8%
6.31
USD 1,894,410
|
300,000
+3.8%
|
6.31
|
USD 1,894,410
|
|
|
2022-01-07 |
2022-01-05 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
250,000
+3.2%
6.30
USD 1,574,650
|
250,000
+3.2%
|
6.30
|
USD 1,574,650
|
|
|
2021-12-16 |
2021-12-16 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
146,685
+2.2%
7.07
USD 1,037,752
|
146,685
+2.2%
|
7.07
|
USD 1,037,752
|
|
|
2021-12-15 |
2021-12-15 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
180,744
+2.7%
6.77
USD 1,223,637
|
180,744
+2.7%
|
6.77
|
USD 1,223,637
|
|
|
2021-12-15 |
2021-12-14 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
94,103
+1.4%
6.81
USD 640,936
|
94,103
+1.4%
|
6.81
|
USD 640,936
|
|
|
2021-12-15 |
2021-12-13 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
187,391
+3.0%
7.08
USD 1,326,803
|
187,391
+3.0%
|
7.08
|
USD 1,326,803
|
|
|
2021-12-10 |
2021-12-10 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
768,171
+13.8%
7.18
USD 5,511,627
|
768,171
+13.8%
|
7.18
|
USD 5,511,627
|
|
|
2021-12-10 |
2021-12-09 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
264,644
+5.0%
7.58
USD 2,007,087
|
264,644
+5.0%
|
7.58
|
USD 2,007,087
|
|
|
2021-12-10 |
2021-12-08 |
B
Purchase
|
Rubric Capital Management LP
Large shareholder
|
560,691
+11.8%
8.02
USD 4,497,078
|
560,691
+11.8%
|
8.02
|
USD 4,497,078
|
|
|
2021-10-01 |
2021-09-29 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
100,000
+1.3%
12.95
USD 1,294,500
|
100,000
+1.3%
|
12.95
|
USD 1,294,500
|
|
|
2021-03-09 |
2021-03-05 |
PS
Planned sale
|
Chopas James George
Principal Finance Accounting
Officer
|
370
-5.2%
20.88
USD 7,726
|
370
-5.2%
|
20.88
|
USD 7,726
|
|
|
2021-02-26 |
2021-02-25 |
S
Sale
|
Grausso Sal
Chief Commercial Officer
Officer
|
1,322
-10.1%
18.93
USD 25,025
|
1,322
-10.1%
|
18.93
|
USD 25,025
|
|
|
2020-11-09 |
2020-11-05 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
100,000
+1.4%
14.26
USD 1,426,230
|
100,000
+1.4%
|
14.26
|
USD 1,426,230
|
|
|
2020-09-16 |
2020-09-14 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
200,000
+2.8%
11.69
USD 2,338,680
|
200,000
+2.8%
|
11.69
|
USD 2,338,680
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
199,029
+2.9%
11.33
USD 2,255,118
|
199,029
+2.9%
|
11.33
|
USD 2,255,118
|
|
|
2020-07-09 |
2020-07-08 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
25,000
+0.4%
13.21
USD 330,178
|
25,000
+0.4%
|
13.21
|
USD 330,178
|
|
|
2020-05-04 |
2020-04-30 |
B
Purchase
|
BIOTECH TARGET N V
Large shareholder
|
50,000
+0.7%
15.75
USD 787,555
|
50,000
+0.7%
|
15.75
|
USD 787,555
|
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Hughes Owen
Non-Executive Director
|
2,750
-20.5%
17.95
USD 49,363
|
2,750
-20.5%
|
17.95
|
USD 49,363
|
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Carmona Jose
Chief Financial Officer
Officer
|
1,292
-2.7%
17.93
USD 23,169
|
1,292
-2.7%
|
17.93
|
USD 23,169
|
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Dere Willard H
Non-Executive Director
|
1,925
-13.6%
17.95
USD 34,554
|
1,925
-13.6%
|
17.95
|
USD 34,554
|
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Morris Charles Q
Chief Medical Officer
Officer
|
1,256
-3.6%
17.93
USD 22,524
|
1,256
-3.6%
|
17.93
|
USD 22,524
|
|
|
2020-02-28 |
2020-02-26 |
PS
Planned sale
|
Rosenberg Anthony
Non-Executive Director
|
1,815
-12.8%
17.95
USD 32,579
|
1,815
-12.8%
|
17.95
|
USD 32,579
|
|
|
2020-02-28 |
2020-02-26 |
S
Sale
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Officer
|
889
-3.6%
17.93
USD 15,942
|
889
-3.6%
|
17.93
|
USD 15,942
|
|
|
2019-11-08 |
2019-11-06 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.5%
23.00
USD 2,300,300
|
100,000
+1.5%
|
23.00
|
USD 2,300,300
|
|
|
2019-07-03 |
2019-07-01 |
PS
Planned sale
|
Rosenberg Anthony
|
1,584
-15.4%
24.60
USD 38,966
|
1,584
-15.4%
|
24.60
|
USD 38,966
|
|
|
2019-06-11 |
2019-06-07 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2,500
+50.0%
21.81
USD 54,536
|
2,500
+50.0%
|
21.81
|
USD 54,536
|
|
|
2019-05-13 |
2019-05-10 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2,000
+66.7%
21.43
USD 42,860
|
2,000
+66.7%
|
21.43
|
USD 42,860
|
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Dere Willard H
|
1,680
-16.3%
22.22
USD 37,330
|
1,680
-16.3%
|
22.22
|
USD 37,330
|
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Graves Kurt
|
4,800
-46.6%
22.32
USD 107,136
|
4,800
-46.6%
|
22.32
|
USD 107,136
|
|
|
2019-04-18 |
2019-04-16 |
PS
Planned sale
|
Hughes Owen
|
2,400
-23.3%
22.22
USD 53,328
|
2,400
-23.3%
|
22.22
|
USD 53,328
|
|
|
2019-04-12 |
2019-04-11 |
PS
Planned sale
|
Roychowdhury Debasish
|
4,800
-46.6%
22.15
USD 106,320
|
4,800
-46.6%
|
22.15
|
USD 106,320
|
|
|
2019-03-06 |
2019-03-05 |
B
Purchase
|
Hopfield Jessica
|
12,800
+inf%
19.23
USD 246,190
|
12,800
+inf%
|
19.23
|
USD 246,190
|
|
|
2018-12-21 |
2018-12-20 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
14.48
USD 868,782
|
60,000
+0.9%
|
14.48
|
USD 868,782
|
|
|
2018-12-18 |
2018-12-17 |
B
Purchase
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Officer
|
3,000
+inf%
15.71
USD 47,130
|
3,000
+inf%
|
15.71
|
USD 47,130
|
|
|
2018-12-17 |
2018-12-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
15.64
USD 938,256
|
60,000
+0.9%
|
15.64
|
USD 938,256
|
|
|
2018-08-22 |
2018-08-20 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+0.9%
19.65
USD 1,178,808
|
60,000
+0.9%
|
19.65
|
USD 1,178,808
|
|
|
2018-08-16 |
2018-08-15 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
69,363
+1.1%
20.78
USD 1,441,530
|
69,363
+1.1%
|
20.78
|
USD 1,441,530
|
|
|
2018-08-16 |
2018-08-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.6%
20.87
USD 2,086,880
|
100,000
+1.6%
|
20.87
|
USD 2,086,880
|
|
|
2018-08-10 |
2018-08-08 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.0%
22.73
USD 1,363,884
|
60,000
+1.0%
|
22.73
|
USD 1,363,884
|
|
|
2018-07-30 |
2018-07-27 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
24.81
USD 1,240,605
|
50,000
+0.8%
|
24.81
|
USD 1,240,605
|
|
|
2018-07-26 |
2018-07-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
27.28
USD 1,363,805
|
50,000
+0.8%
|
27.28
|
USD 1,363,805
|
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.8%
27.36
USD 1,367,835
|
50,000
+0.8%
|
27.36
|
USD 1,367,835
|
|
|
2018-05-24 |
2018-05-23 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.7%
28.91
USD 1,156,320
|
40,000
+0.7%
|
28.91
|
USD 1,156,320
|
|
|
2018-05-23 |
2018-05-21 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.0%
29.27
USD 1,756,380
|
60,000
+1.0%
|
29.27
|
USD 1,756,380
|
|
|
2018-04-23 |
2018-04-19 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.7%
33.80
USD 1,351,936
|
40,000
+0.7%
|
33.80
|
USD 1,351,936
|
|
|
2018-04-09 |
2018-04-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
36.58
USD 1,828,845
|
50,000
+0.9%
|
36.58
|
USD 1,828,845
|
|
|
2018-03-06 |
2018-03-02 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
80,000
+1.4%
32.52
USD 2,601,448
|
80,000
+1.4%
|
32.52
|
USD 2,601,448
|
|
|
2018-02-12 |
2018-02-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.3%
34.38
USD 2,578,763
|
75,000
+1.3%
|
34.38
|
USD 2,578,763
|
|
|
2017-11-16 |
2017-11-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
26.25
USD 1,312,390
|
50,000
+0.9%
|
26.25
|
USD 1,312,390
|
|
|
2017-11-13 |
2017-11-10 |
B
Purchase
|
Hatzis-Schoch Brent
Sr. VP, General Counsel
|
1,778
+355.6%
28.09
USD 49,943
|
1,778
+355.6%
|
28.09
|
USD 49,943
|
|
|
2017-11-07 |
2017-11-07 |
B
Purchase
|
Hoiland Jesper
President and CEO
Executive Director
|
6,800
+111.5%
29.04
USD 197,450
|
6,800
+111.5%
|
29.04
|
USD 197,450
|
|
|
2017-11-07 |
2017-11-03 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
29.15
USD 1,457,575
|
50,000
+0.9%
|
29.15
|
USD 1,457,575
|
|
|
2017-10-27 |
2017-10-26 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
30.95
USD 1,547,550
|
50,000
+0.9%
|
30.95
|
USD 1,547,550
|
|
|
2017-10-26 |
2017-10-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
32.85
USD 1,642,415
|
50,000
+0.9%
|
32.85
|
USD 1,642,415
|
|
|
2017-09-15 |
2017-09-15 |
B
Purchase
|
Hoiland Jesper
President and CEO
Executive Director
|
6,100
+inf%
32.72
USD 199,608
|
6,100
+inf%
|
32.72
|
USD 199,608
|
|
|
2017-09-15 |
2017-09-14 |
B
Purchase
|
Carmona Jose
Chief Financial Officer
|
3,000
+inf%
32.83
USD 98,503
|
3,000
+inf%
|
32.83
|
USD 98,503
|
|
|
2017-09-15 |
2017-09-14 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
32.94
USD 1,647,225
|
50,000
+0.9%
|
32.94
|
USD 1,647,225
|
|
|
2017-09-15 |
2017-09-13 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
100,000
+1.9%
33.71
USD 3,370,750
|
100,000
+1.9%
|
33.71
|
USD 3,370,750
|
|
|
2017-09-13 |
2017-09-12 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+0.9%
35.42
USD 1,770,820
|
50,000
+0.9%
|
35.42
|
USD 1,770,820
|
|
|
2017-09-07 |
2017-09-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
36.75
USD 1,837,625
|
50,000
+1.0%
|
36.75
|
USD 1,837,625
|
|
|
2017-08-18 |
2017-08-16 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
60,000
+1.2%
35.98
USD 2,158,536
|
60,000
+1.2%
|
35.98
|
USD 2,158,536
|
|
|
2017-08-11 |
2017-08-10 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.5%
34.26
USD 2,569,500
|
75,000
+1.5%
|
34.26
|
USD 2,569,500
|
|
|
2017-08-11 |
2017-08-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
75,000
+1.5%
35.67
USD 2,675,528
|
75,000
+1.5%
|
35.67
|
USD 2,675,528
|
|
|
2017-05-31 |
2017-05-30 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.8%
34.21
USD 1,368,348
|
40,000
+0.8%
|
34.21
|
USD 1,368,348
|
|
|
2017-05-30 |
2017-05-25 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
40,000
+0.8%
36.25
USD 1,450,020
|
40,000
+0.8%
|
36.25
|
USD 1,450,020
|
|
|
2017-05-22 |
2017-05-18 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
34.41
USD 1,720,345
|
50,000
+1.0%
|
34.41
|
USD 1,720,345
|
|
|
2017-05-18 |
2017-05-17 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
18,000
+0.4%
32.98
USD 593,662
|
18,000
+0.4%
|
32.98
|
USD 593,662
|
|
|
2017-05-18 |
2017-05-16 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
17,000
+0.3%
33.93
USD 576,725
|
17,000
+0.3%
|
33.93
|
USD 576,725
|
|
|
2017-05-16 |
2017-05-12 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
15,000
+0.3%
34.00
USD 509,996
|
15,000
+0.3%
|
34.00
|
USD 509,996
|
|
|
2017-05-11 |
2017-05-09 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
50,000
+1.0%
35.93
USD 1,796,480
|
50,000
+1.0%
|
35.93
|
USD 1,796,480
|
|
|
2017-05-09 |
2017-05-08 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
22,800
+0.5%
35.60
USD 811,630
|
22,800
+0.5%
|
35.60
|
USD 811,630
|
|
|
2017-05-09 |
2017-05-05 |
B
Purchase
|
BIOTECH GROWTH N V
Large shareholder
|
20,600
+0.4%
35.55
USD 732,283
|
20,600
+0.4%
|
35.55
|
USD 732,283
|
|
